Bhavna Karnani

Bhavna Karnani

Bhavna is a young researcher at the National Institute of Molecular Genetics (INGM) in Milan, Italy. Her Alma Mater is the Florida Institute of Technology from which she graduated with honors in Biochemistry. She continued her education at ETH Zurich where she gained a Microbiology and Immunology master degree with research experience centered on human nutrition, food microbiology and biochemistry. She is now actively involved in the research of human regulatory T-cells in cancer.

Bhavna's latest articles

The gene editing technology notoriously known as CRISPR/Cas9 has gained vast attention after the Chinese scientist He Jiankui claimed he had, for the first time ever, created gene-edited twins. While He has received negative criticism for his work amongst the scientific community, many believe the world can benefit from this powerful technology. He Jiankui has decided that the world is ready for germline gene editing, but does the rest of the world feel the same?

The alarming rise of measles across Europe and the US has health officials scrambling to contain the damage of what is being called the worst outbreak of the 21st century – the anti-vaxxer epidemic. Vaccines have become a victim of their own success, and the mistrust in their use demands a global effort to understand what has caused this behavioral shift, and resulted in a society wanting to take one step backwards rather than a leap forward.

Older articles

Culturico's logo

25.10.2018 – Antibiotics have become a daily part of our lives. According to the World Health Organization “Antibiotic resistance is one of the biggest threats to global health, food security, and development today”. Antibiotics have clearly become a double-edged sword and there is now a great need to raise awareness on the beneficial roles of bacteria and highlight alternative strategies to fight back against antibiotic resistance.

READ THE ARTICLE…